Literature DB >> 24848633

The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis.

Loïc Le Guennec1, Caroline Decaix, Jean Donadieu, Maria Santiago-Ribeiro, Nadine Martin-Duverneuil, Richard Levy, Daniel Delgadillo, Aurélie Kas, Aurélie Drier, Laurent Magy, Eleonore Bayen, Khe Hoang-Xuan, Ahmed Idbaih.   

Abstract

Clinical spectrum of cognitive troubles complicating neurodegenerative Langerhans cell histiocytosis (ND-LCH) is poorly known. The aim of this study is to evaluate cognitive functions in ND-LCH. The cognitive functions of a series of eight adult patients (7 males and 1 female; mean age 26 years IQ 25-75; range 20-33) suffering from clinical and/or radiological ND-LCH were evaluated using the following tests: (1) forward/backward digit and spatial span tasks of the WAIS-R scale and the Corsi block task, (2) the French version of the free and cued selective reminding test, (3) verbal fluency tests, (4) the Frontal Assessment Battery (FAB), (5) backward measurement of the verbal and visuospatial memories of the WAIS-R scale, (6) the Rey complex figure test, (7) the trail making tests A and B, (8) digit symbol and symbol search of the WAIS-IV scale, and (9) the Stroop test. Episodic (i.e. autobiographical or personal) memory free recall, categorical verbal fluency, phonological verbal fluency, visuospatial processing skills, attention, speed of processing, and sensitivity to interference were impaired in ND-LCH patients. In contrast, verbal and visuospatial short-term memories (i.e. immediate memories or forward span tasks) were preserved in all patients. Adult ND-LCH patients suffer from a severe but dissociated dysexecutive syndrome, mostly affecting executive strategies and relatively sparing short-term memory. Our study supports the need of assessing executive functions using comprehensive cognitive evaluation in ND-LCH patients for early diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 24848633     DOI: 10.1007/s00415-014-7375-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Trail Making Test A and B: normative data stratified by age and education.

Authors:  Tom N Tombaugh
Journal:  Arch Clin Neuropsychol       Date:  2004-03       Impact factor: 2.813

Review 2.  Cognitive rehabilitation interventions for executive function: moving from bench to bedside in patients with traumatic brain injury.

Authors:  Keith Cicerone; Harvey Levin; James Malec; Donald Stuss; John Whyte
Journal:  J Cogn Neurosci       Date:  2006-07       Impact factor: 3.225

3.  Executive dysfunction and neuropsychological testing.

Authors:  Bruno Dubois; Katia Andrade; Richard Levy
Journal:  Handb Clin Neurol       Date:  2008

4.  A rapprochement between emotion and cognition: amygdala, emotion, and self-relevance in episodic-autobiographical memory.

Authors:  Angelica Staniloiu; Hans J Markowitsch
Journal:  Behav Brain Sci       Date:  2012-06       Impact factor: 12.579

5.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

6.  Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study.

Authors:  D Laplane; M Levasseur; B Pillon; B Dubois; M Baulac; B Mazoyer; S Tran Dinh; G Sette; F Danze; J C Baron
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

7.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

8.  A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.

Authors: 
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

9.  Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study.

Authors:  Ahmed Idbaih; J Donadieu; M A Barthez; F Geissmann; Y Bertrand; O Hermine; L Brugières; T Genereau; C Thomas; K Hoang-Xuan
Journal:  Pediatr Blood Cancer       Date:  2004-07       Impact factor: 3.167

10.  Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status.

Authors:  R K Mulhern; E Kovnar; J Langston; M Carter; D Fairclough; L Leigh; L E Kun
Journal:  J Clin Oncol       Date:  1992-07       Impact factor: 44.544

View more
  3 in total

Review 1.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

Review 2.  Langerhans cell histiocytosis: Case report and literature review

Authors:  Miguel Ángel Medina; Wendy Meyer; Carolina Echeverri; Natalia Builes
Journal:  Biomedica       Date:  2021-09-22       Impact factor: 0.935

3.  Early Diagnosis and Monitoring of Neurodegenerative Langerhans Cell Histiocytosis.

Authors:  Elena Sieni; Carmen Barba; Marzia Mortilla; Sara Savelli; Laura Grisotto; Gianpiero Di Giacomo; Katiuscia Romano; Claudio Fonda; Annibale Biggeri; Renzo Guerrini; Maurizio Aricò
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.